Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Good morning Americas. Here’s news from Bloomberg Economics to help get your Wednesday started:
China has hit back at U.S. President Donald Trump’s plan to push ahead with tariffs on $50 billion of Chinese imports despite a recent truce in the trade fight, saying it damages America’s standingJust when central bankers thought they were about to get out of the business....More>>>
Celgene (NASDAQ: CELG) is a more than $80 billion biotech company that hurt its investors in late October, after a difficult environment forced the company to cut its growth forecasts. However, the company operates in growing markets, and still has what’s arguably the best portfolio of assets in the biotech industry. Its market-leading portfolio, especially after its acquisition of Impact....More>>>
Bank of America’s (NYSE:BAC) shares suddenly dropped last week, slumping ~6 percent on Tuesday as investors rushed to sell financials and take profits in stocks that have soared since the U.S. election. Republicans also don’t appear to be able to score legislative victories as easily as investors thought, which raises concerns over the sustainability of the Trump rally.
Another reversal higher to new highs for the major markets today as stocks continue to ride a wave of speculative trading along with sector rotations and the ongoing prospects for a tax overhaul before the end of the year.
It all adds up to a rally that still has room to move higher.
Seemingly, the only test that stocks must face over the next month is the earnings season, which somewhat....More>>>
Despite facing a $400 million budget hole, Delaware is the latest state to repeal its estate tax—as of Jan. 1, 2018. Democratic Governor John Carney Jr. signed a stand-alone estate tax repeal bill today, just two days after signing the 2018 state budget, which includes tax hikes on real estate transfers, tobacco and alcohol.
“The very wealthy don’t have to move down to Florida,”....More>>>
Portland, OR, based Investment company Portfolio 21 Investments buys Westinghouse Air Brake Technologies Corp, Danaher Corp, FedEx Corp, S&P Global Inc, sells General Mills Inc, United Parcel Service Inc, Verizon Communications Inc, General Electric Co during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Portfolio 21 Investments. As of 2017-06-30,....More>>>
Iconix Brand Group (NASDAQ:ICON) announced it is selling off its stake in Charles Schultz’s Peanuts cartoons. The beloved Charlie Brown and his fellow Peanuts characters are being used to help get the company back on firm financial footing.
Getting out of the entertainment biz
The company announced on the morning of May 10 that it was closing down its entertainment segment,....More>>>
How to play the turnaround in the Brazilian economy
Investing in emerging markets always has a heightened amount of risk associated with it. However, large and mid-cap stocks can help mitigate the heightened amount of risk. This is why I believe that the iShares MSCI Brazil Index (EWZ) is the safest way to play the turnaround in the Brazilian economy. The MSCI Brazil 25/50 Index is designed....More>>>
Can we be honest here? It was yet another Warren Buffett shareholder weekend. That meant another year of Twitter pics of journos sticking mics in front of Buffett's face while he walked a convention floor holding a Dilly bar, another year of interviews of Buffett shareholders that have held the
The best investments are those where, opposite to popular opinion, one does not have to be the smartest person in the room. The best investments are ones where the odds of success are so far tilted to ones favor that even if so much can be wrong in one thesis, you still end up d
Along with the February traffic numbers, Delta Air Lines (NYSE:DAL) reported a key stat returned to flat after an extended period of negative prints. The stock, though, shook off the improving trend with an initial decline due to the weak market.
In the aftermath of Antares Pharma (ATRS) falling from $4.09 in mid-October to $1.58 by mid-November 2017 after it was learned that the FDA had issued a CRL for the company's TRT (testosterone replacement therapy) drug Xyosted, the stock has made a slow comeback beginning in December to a curren